Abstract session: Hepatitis B - Translational

 Viral hepatitis

Channel 5
Abstract session
27 August 2020 11:00 - 12:30


Title Time

Add to Calendar

AS001 Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity
27 August 2020 11:00 - 11:15
AS002 Targeting inhibitor of apoptosis proteins (IAPs) enhances intrahepatic antiviral immunity to clear hepatitis B virus infection in vivo
27 August 2020 11:15 - 11:30
AS003 Serum and intrahepatic HBV markers and HBV-specific CD8 T cell responses after nucleos(t)ide analog therapy discontinuation in HBeAg-negative chronic hepatitis B patients.
27 August 2020 11:30 - 11:45
AS004 Targeted long read sequencing reveals the comprehensive architecture and expression patterns of integrated HBV DNA in CHB liver biopsies
27 August 2020 11:45 - 12:00
AS005 Transcriptome analysis of paired liver biopsies identifies correlates of HBsAg response in placebo and TDF treated CHB patients
27 August 2020 12:00 - 12:15
AS006 Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUC+HBIG prophylaxis
27 August 2020 12:15 - 12:30